» Articles » PMID: 31509966

E-cadherin Downregulation and MicroRNAs in Sporadic Intestinal-Type Gastric Cancer

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Sep 13
PMID 31509966
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

gene, encoding E-cadherin, is a tumor suppressor gene frequently altered in gastric cancers (GCs) of both diffuse (DGC) and intestinal (IGC) histotypes, albeit through different mechanisms. The study aimed to characterize expression in sporadic IGC and to investigate whether microRNAs (miRs) are involved in its transcriptional control. We evaluated expression by quantitative real-time PCR (RT-qPCR) in 33 IGC patients and found a significant downregulation in tumor tissues compared to normal counterparts (-value = 0.025). Moreover, 14 miRs, predicted to be involved in regulation in both a direct and indirect manner, were selected and analyzed by RT-qPCR in an independent case series of 17 IGCs and matched normal tissues. miR-101, miR-26b, and miR-200c emerged as significantly downregulated and were confirmed in the case series of 33 patients (-value < 0.001). Finally, we evaluated expression, a target of both miR-101 and miR-26b, which showed significant upregulation in IGCs (-value = 0.005). A significant inverse correlation was observed between overexpression and , miR-101, and miR-26b levels (-value < 0.001). Our results reinforce the link between and IGC, highlighting the role of miRs in its transcriptional control and improving our understanding of GC subtypes and biomarkers.

Citing Articles

Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric adenocarcinomas.

Cretu O, Simionescu C, Florescu M, Stepan M, Sapalidis K, Stepan A Rom J Morphol Embryol. 2023; 63(3):529-537.

PMID: 36588491 PMC: 9926152. DOI: 10.47162/RJME.63.3.07.


Editorial to the Special Issue "Activations of Cadherin Signaling in Cancer".

Tomassetti A Int J Mol Sci. 2022; 23(13).

PMID: 35806026 PMC: 9266632. DOI: 10.3390/ijms23137022.


Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle Trafficking.

Brew T, Bougen-Zhukov N, Mitchell W, Decourtye L, Schulpen E, Nouri Y Cancers (Basel). 2022; 14(1).

PMID: 35008266 PMC: 8749886. DOI: 10.3390/cancers14010102.


The Molecular Roles and Clinical Implications of Non-Coding RNAs in Gastric Cancer.

Yue Y, Lin X, Qiu X, Yang L, Wang R Front Cell Dev Biol. 2021; 9:802745.

PMID: 34966746 PMC: 8711095. DOI: 10.3389/fcell.2021.802745.


Aspects of the Epigenetic Regulation of EMT Related to Cancer Metastasis.

Nowak E, Bednarek I Cells. 2021; 10(12).

PMID: 34943943 PMC: 8700111. DOI: 10.3390/cells10123435.


References
1.
Jansson M, Lund A . MicroRNA and cancer. Mol Oncol. 2012; 6(6):590-610. PMC: 5528350. DOI: 10.1016/j.molonc.2012.09.006. View

2.
Carvalho J, Van Grieken N, Pereira P, Sousa S, Tijssen M, Buffart T . Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. J Pathol. 2012; 228(1):31-44. DOI: 10.1002/path.4032. View

3.
Torabizadeh Z, Nosrati A, Sajadi Saravi S, Yazdani Charati J, Janbabai G . Evaluation of E-cadherin Expression in Gastric Cancer and Its Correlation with Clinicopathologic Parameters. Int J Hematol Oncol Stem Cell Res. 2017; 11(2):158-164. PMC: 5575728. View

4.
Song Y, Ye M, Zhou J, Wang Z, Zhu X . Targeting E-cadherin expression with small molecules for digestive cancer treatment. Am J Transl Res. 2019; 11(7):3932-3944. PMC: 6684918. View

5.
Li F, Xu B, Wu Y, Yang Z, Qian J . Differential microRNA expression in signet-ring cell carcinoma compared with tubular adenocarcinoma of human gastric cancer. Genet Mol Res. 2015; 14(1):739-47. DOI: 10.4238/2015.January.30.17. View